|
GTF2H1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44999999999829E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.97259999965705E-07 |
| Normal-vs-Stage2 |
3.909500E-02 |
| Normal-vs-Stage3 |
3.914000E-01 |
| Normal-vs-Stage4 |
3.751000E-01 |
| Stage1-vs-Stage2 |
3.146600E-01 |
| Stage1-vs-Stage3 |
1.433990E-02 |
| Stage1-vs-Stage4 |
1.100780E-01 |
| Stage2-vs-Stage3 |
3.547400E-01 |
| Stage2-vs-Stage4 |
4.467200E-01 |
| Stage3-vs-Stage4 |
9.658200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6307299999907E-05 |
| Normal-vs-AfricanAmerican |
6.844400E-03 |
| Normal-vs-Asian |
9.358400E-01 |
| Caucasian-vs-AfricanAmerican |
2.734000E-01 |
| Caucasian-vs-Asian |
1.302250E-01 |
| AfricanAmerican-vs-Asian |
2.417600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.05249999949164E-07 |
| Normal-vs-Female |
2.185000E-01 |
| Male-vs-Female |
2.035200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.264500E-02 |
| Normal-vs-Extreme_Weight |
5.2445000009449E-08 |
| Normal-vs-Obese |
5.301100E-03 |
| Normal-vs-Extreme_Obese |
3.256200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.018980E-01 |
| Normal_Weight-vs-Obese |
8.680400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.914000E-01 |
| Extreme_Weight-vs-Obese |
2.192500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.509600E-01 |
| Obese-vs-Extreme_Obese |
4.794000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.119200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.962080E-03 |
| Normal-vs-Age(61-80Yrs) |
4.43839999975104E-07 |
| Normal-vs-Age(81-100Yrs) |
7.469700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.555800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.677920E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.866500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.126400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.017000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.603000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.78420000072211E-08 |
| Normal-VS-Type2 PRCC |
1.348210E-01 |
| Normal-VS-KIRP CIMP |
5.605200E-01 |
| Normal-VS-Unclassified PRCC |
6.975900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.622100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.682000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.130230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.889850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.498800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.197000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.88440000000023E-05 |
| Normal-vs-N1 |
5.862000E-01 |
| Normal-vs-N2 |
6.556500E-03 |
| N0-vs-N1 |
1.118820E-03 |
| N0-vs-N2 |
6.794800E-01 |
| N1-vs-N2 |
8.884000E-02 |
|
|
